Please login to read the full article.
Scrip Regulatory Affairs
US FDA consults on creating external expert network for emerging medical devices
05 October 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA consults drug companies on best approaches to REMS assessment
- US FDA sets 30 June deadline for finalising companion diagnostics guidance; publishes other device priorities
- US FDA SOP seeks to convey new regulatory expectations to medtech firms faster
- Will accelerated approval, antibiotic add-ons bog down PDUFA in US?
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
